dronabinol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| England, TJ; Murphy, AJ; O'Sullivan, SE; Stone, NL | 1 |
| Appendino, G; Bellido, ML; Cantarero, I; Casano, S; Del Río, C; Ferreiro-Vera, C; Meyer, S; Morello, G; Muñoz, E; Nadal, X; Navarrete, C; Palomares, B; Sánchez-Carnerero, C | 1 |
| Djamshidian, A; Heim, B; Lücke, T; Peball, M; Saft, C; Seppi, K; Thiels, C; von Hein, SM | 1 |
| Alonso Arias, MA; Fernández Ruiz, J; Galve-Roperh, I; García Caldentey, J; García de Yébenes Prous, J; García de Yébenes, MJ; García Ribas, G; García-Bermejo, ML; Guzmán, M; López-Sendón Moreno, JL; Ortega-Gutierrez, S; Resel, E; Ruiz Romero, C; Sagredo, O; Tolón, RM; Trigo Cubillo, P; Valdeolivas, S | 1 |
| Curtis, A; Ives, N; Mitchell, I; Patel, S; Rickards, H | 1 |
| Dragunow, M; Glass, M; Goodfellow, CE; Graham, ES; Scotter, EL | 1 |
| Dowie, MJ; Faull, RL; Glass, M; Hannan, AJ; Howard, ML; Nicholson, LF | 1 |
| Aguado, T; Alberch, J; Benito, C; Blázquez, C; Börner, C; Carrasco, C; Chiarlone, A; de Yébenes, JG; Díaz-Hernández, M; Diez-Zaera, M; Fernández-Ruiz, J; Galve-Roperh, I; Ginés, S; Guzmán, M; Julien, B; Kraus, J; Lucas, JJ; Lutz, B; Marsicano, G; Monory, K; Palazuelos, J; Paoletti, P; Pazos, MR; Resel, E; Romero, J; Ruiz, C; Sagredo, O; Salazar, M; Sendtner, M | 1 |
| Fernández-Ruiz, J; Pazos, MR; Pertwee, RG; Ramos, JA; Sagredo, O; Satta, V | 1 |
| Armida, M; Beggiato, S; Chiodi, V; Domenici, MR; Ferrante, A; Ferraro, L; Martire, A; Popoli, P; Potenza, RL; Tanganelli, S; Uchigashima, M; Watanabe, M | 1 |
| Fernández-Ruiz, J; Pertwee, RG; Sagredo, O; Satta, V; Valdeolivas, S | 1 |
| Bizat, N; Boyer, F; Brouillet, E; Fernández-Ruiz, J; Hantraye, P; Lastres-Becker, I | 1 |
| Curtis, A; Rickards, H | 1 |
| Emrich, HM; Müller-Vahl, KR; Schneider, U | 1 |
| Consroe, P; Kennedy, K; Schram, K | 1 |
1 review(s) available for dronabinol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
A systematic review of minor phytocannabinoids with promising neuroprotective potential.
Topics: Cannabidiol; Dronabinol; Humans; Huntington Disease; Seizures | 2020 |
4 trial(s) available for dronabinol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
Topics: Adult; Amino Acids; Amyloid beta-Peptides; Biogenic Monoamines; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Combinations; Endocannabinoids; Female; Fibroblasts; Follow-Up Studies; Gene Expression Regulation; Humans; Huntington Disease; Male; Mental Status Schedule; MicroRNAs; Middle Aged; Outcome Assessment, Health Care; Peptide Fragments; Pilot Projects; Plant Extracts; Plant Structures; Severity of Illness Index; tau Proteins | 2016 |
A pilot study using nabilone for symptomatic treatment in Huntington's disease.
Topics: Adult; Aged; Anti-Anxiety Agents; Behavioral Symptoms; Cognition Disorders; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Huntington Disease; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Pilot Projects | 2009 |
Nabilone increases choreatic movements in Huntington's disease.
Topics: Chorea; Dronabinol; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests | 1999 |
Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cannabidiol; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Huntington Disease; Male; Middle Aged | 1991 |
10 other study(ies) available for dronabinol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Topics: Animals; Cannabis; Cell Line, Tumor; Disease Models, Animal; Dronabinol; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Nitro Compounds; PPAR gamma; Propionates | 2017 |
Cannabinoids for Treatment of Dystonia in Huntington's Disease.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Dystonia; Female; Humans; Huntington Disease; Male; Treatment Outcome | 2018 |
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.
Topics: Animals; Butadienes; Cell Culture Techniques; Cell Death; Cell Line, Transformed; Cerebellum; Cyclic AMP; Dronabinol; GTP-Binding Protein alpha Subunits; Humans; Huntingtin Protein; Huntington Disease; Mice; Mitogen-Activated Protein Kinase 3; Nerve Tissue Proteins; Neuroprotective Agents; Nitriles; Nuclear Proteins; PC12 Cells; Pertussis Toxin; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptors, Dopamine; Rimonabant | 2010 |
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Topics: Animals; Behavior, Animal; Cannabinoids; Cohort Studies; Corpus Striatum; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Huntington Disease; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Random Allocation; Receptor, Cannabinoid, CB1; Treatment Outcome | 2010 |
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Survival; Corpus Striatum; Dronabinol; Growth Hormone-Releasing Hormone; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Motor Activity; Neurons; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; Rotarod Performance Test | 2011 |
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
Topics: Animals; Cannabidiol; Cannabinoids; Caudate Nucleus; Cells, Cultured; Disease Models, Animal; Disease Progression; Dronabinol; Drug Combinations; Huntington Disease; Male; Neostriatum; Neuroprotective Agents; Phytotherapy; Plant Extracts; Putamen; Rats; Rats, Sprague-Dawley | 2011 |
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.
Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Brain; Disease Models, Animal; Dronabinol; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agents; gamma-Aminobutyric Acid; Glutamates; Humans; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Morpholines; Motor Activity; Naphthalenes; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Piperidines; Potassium; Pyrazoles; Receptor, Cannabinoid, CB1; Statistics, Nonparametric; Synaptosomes; Trinucleotide Repeats; Tritium; Vesicular Glutamate Transport Protein 1; Vesicular Inhibitory Amino Acid Transport Proteins | 2012 |
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Topics: Animals; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Combinations; Drug Therapy, Combination; Huntington Disease; Inflammation; Male; Malonates; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabinoids; Corpus Striatum; Disease Models, Animal; Dronabinol; Electron Transport Complex II; Enzyme Inhibitors; Huntington Disease; Male; Malonates; Multienzyme Complexes; Oxidoreductases; Piperidines; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Succinate Dehydrogenase | 2003 |
Nabilone could treat chorea and irritability in Huntington's disease.
Topics: Adult; Anti-Anxiety Agents; Dronabinol; Female; Humans; Huntington Disease | 2006 |